Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen is offering a PhD project commencing 1/1 2011 or soon thereafter. The application deadline is December 1st 2010.
The Faculty of Life Science and Novo Nordisk A/S have recently established a research centre - The Novo Nordisk-LIFE In Vivo Pharmacology Centre (NNLIVPC) - with a total budget of DKK 68 mill covering activities until end 2018. The present positions are part of the new Centre´s activities. The purpose of the research centre is to strengthen the research in experimental pharmacology and toxicology and to increase the output of candidates and PhDs with a strong in vivo pharmacological profile. It is expected that the future PhD fellows will be enrolled in the In Vivo Pharmacology PhD program at LIFE and participate actively in this network. The In Vivo Pharmacology PhD program was established in 2006 as a collaboration between the Faculties of Life Sciences, Pharmaceutical Sciences and Health Sciences at the University of Copenhagen, University of Aarhus, and industrial partners; Novo Nordisk A/S, LEO Pharma and H. Lundbeck A/S.
Obesity, increased visceral fat mass, and liver steatosis (fat in liver) are factors associated with increased risk of developing cardiovascular disease. A common side effect following insulin therapy is weight gain - an issue for patients with type 2 diabetes as they often are obese when starting on insulin therapy. At present, the association between insulin-induced weight gain in type 2 diabetic individuals and the risk of developing cardiovascular disease is unclear.
With this project we wish to i) establish how insulin-induced obesity is associated with visceral fat mass and liver steatosis in an animal model of type 2 diabetes, ii) investigate how such changes are associated with relevant blood and tissue markers of inflammation and cardiovascular disease, and iii) investigate how insulin-induced weight gain in patients with type 2 diabetes is associated with changes in markers of cardiovascular disease.Contact:
Professor Jens Lykkesfeldt
Direct Phone: (+45) 35333163
Ph D Position In I Psc Based Brain Disease Modelling And Stem Cell Biology, Masaryk University Brno, Faculty of Medicine, Czech, 17 days ago
Job posted by Masaryk University Brno, Faculty of Science (09/04/2015 09.41) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European C...
Ph D Position In The Area Of Pancreatic Diseases, University Hospital Zuerich, Switzerland, 8 days ago
Job posted by University Hospital Zuerich (17/04/2015 15.28) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code ...
Ph D Position At Institut Pasteur And Sanofi, Institut Pasteur, France, 11 days ago
Job posted by Institut Pasteur (15/04/2015 15.55) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code for Researc...
Ph D Position In Molecular Biology The Role Of Dna Damage In The Pathogenesis Of Nitrate Tolerance, International PhD Programme “Dynamics of Gene Regulation, Epigenetics and DNA Damage Response”, Germany, 19 days ago
Job posted by International PhD Programme “Dynamics of Gene Regulation, Epigenetics and DNA Damage Response” (07/04/2015 12.03) Marie Curie Actions. More 'HR Excellence in Research' logo awarded t...
Ph D Fellowship With Focus On Radiochemistry, University of Copenhagen, Denmark, 13 days ago
The Department Cluster for Molecular Imaging runs a core facility for molecular imaging, which is focused on techniques in nuclear medicine (SPECT and PET), radiology (MR and CT) and optical im...
Ph D Studentship – Ph D In Cancer Immunogenetics, The University of Southampton, United Kingdom, 4 days ago
Biological Sciences Research Location: Highfield Campus Closing Date: Friday 22 May 2015 Interview Date: Reference: 554215BJ PhD Studentship –PhD in cancer immunogenetics PhD Supervisor: Dr Hannah...